Spin-Hall effect and circular birefringence of a uniaxial crystal plate

The linear birefringence of uniaxial crystal plates is known since the 17th century, and it is widely used in numerous optical setups and devices. Here we demonstrate, both theoretically and experimentally, a fine lateral circular birefringence of such crystal plates. This effect is a novel example of the spin-Hall effect of light, i.e., a transverse spin-dependent shift of the paraxial light beam transmitted through the plate. The well-known linear birefringence and the new circular birefringence form an interesting analogy with the Goos-H\"anchen and Imbert-Fedorov beam shifts that appear in the light reflection at a dielectric interface. We report the experimental observation of the effect in a remarkably simple system of a tilted half-wave plate and polarizers using polarimetric and quantum-weak-measurement techniques for the beam-shift measurements. In view of great recent interest in spin-orbit interaction phenomena, our results could find applications in modern polarization optics and nano-photonics.Comment: 16 pages, 8 figures, to appear in Optic

Characterization of a birnavirus isolated from diseased turbot cultured in Spain

7 pages, 5 figures, 2 tables.During 1989, light but persistent mortalities were detected in a turbot Scophthalmus maximus L. farm in Galicia (northwestern Spain) and a virus with the characteristics of a birnavirus was isolated. The purpose of this study was to characterize the viral agent and determine the susceptibility of turbot to this virus. Electron microscopic examination revealed that the particles were isometric, hexagonal and unenveloped with an average diameter of 58 to 60 nm. The molecular weights of the RNA segments were 1.9 and 2.0 x 10(up to 6) daltons. The cells most susceptible to the turbot isolate were the CHSE-214, FHM and RTG-2 lines and the optimal temperature range for its replication was 15 to 2OºC. The RNA and polypeptide electropherotypes show that this virus resembles the Ab serotype of infectious pancreatic necrosis virus (IPNV); however, it differs in that it replicates in the FHM cell line and is not neutralized by antisera to the classical serotypes of IPNV. Infectivity trials conducted in turbot of dlfferent sizes indicated that the virus produced mortality only in small fish (2 g), although the larger fish (30 g) harbored the virus for at least 35 d. Fish inoculated with this isolate showed no pancreatic necrosis although necrosis of the hematopoietic elements of the kidney and spleen was detected.This work was supported by Grants MAR 89-0270 from the Comision Interministenal de Ciencia y Tecnologia (CICYT), and by XUGA 70708888 from Xunta de Galicia, Spain. Beatriz Novoa acknowledges the Ministerio de Educacion y Ciencia (Spain) for a research fellowship.Peer reviewe

Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis

PMCID: PMC3856490This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.PMCID: PMC385649

Humoral response to neurofilaments and dipeptide repeats in ALS progression

Abstract Objective To appraise the utility as biomarkers of blood antibodies and immune complexes to neurofilaments and dipeptide repeat proteins, the products of translation of the most common genetic mutation in amyotrophic lateral sclerosis (ALS). Methods Antibodies and immune complexes against neurofilament light, medium, heavy chains as well as poly‐(GP)‐(GR) dipeptide repeats were measured in blood samples from the ALS Biomarkers (n = 107) and the phenotype–genotype biomarker (n = 129) studies and in 140 healthy controls. Target analyte levels were studied longitudinally in 37 ALS cases. Participants were stratified according to the rate of disease progression estimated before and after baseline and C9orf72 genetic status. Survival and longitudinal analyses were undertaken with reference to matched neurofilament protein expression. Results Compared to healthy controls, total neurofilament proteins and antibodies, neurofilament light immune complexes (p < 0.0001), and neurofilament heavy antibodies (p = 0.0061) were significantly elevated in ALS, patients with faster progressing disease (p < 0.0001) and in ALS cases with a C9orf72 mutation (p < 0.0003). Blood neurofilament light protein discriminated better ALS from healthy controls (AUC: 0.92; p < 0.0001) and faster from slower progressing ALS (AUC: 0.86; p < 0.0001) compared to heavy‐chain antibodies and light‐chain immune complexes (AUC: 0.79; p < 0.0001 and AUC: 0.74; p < 0.0001). Lower neurofilament heavy antibodies were associated with longer survival (Log‐rank Chi‐square: 7.39; p = 0.0065). Increasing levels of antibodies and immune complexes between time points were observed in faster progressing ALS. Conclusions We report a distinctive humoral response characterized by raising antibodies against neurofilaments and dipeptide repeats in faster progressing and C9orf72 genetic mutation carriers ALS patients. We confirm the significance of plasma neurofilament proteins in the clinical stratification of ALS

Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial.

BACKGROUND: Tuberculosis remains one of the world's deadliest transmissible diseases despite widespread use of the BCG vaccine. MTBVAC is a new live tuberculosis vaccine based on genetically attenuated Mycobacterium tuberculosis that expresses most antigens present in human isolates of M tuberculosis. We aimed to compare the safety of MTBVAC with BCG in healthy adult volunteers. METHODS: We did this single-centre, randomised, double-blind, controlled phase 1 study at the Centre Hospitalier Universitaire Vaudois (CHUV; Lausanne, Switzerland). Volunteers were eligible for inclusion if they were aged 18-45 years, clinically healthy, HIV-negative and tuberculosis-negative, and had no history of active tuberculosis, chemoprophylaxis for tuberculosis, or BCG vaccination. Volunteers fulfilling the inclusion criteria were randomly assigned to three cohorts in a dose-escalation manner. Randomisation was done centrally by the CHUV Pharmacy and treatments were masked from the study team and volunteers. As participants were recruited within each cohort, they were randomly assigned 3:1 to receive MTBVAC or BCG. Of the participants allocated MTBVAC, those in the first cohort received 5 × 10(3) colony forming units (CFU) MTBVAC, those in the second cohort received 5 × 10(4) CFU MTBVAC, and those in the third cohort received 5 × 10(5) CFU MTBVAC. In all cohorts, participants assigned to receive BCG were given 5 × 10(5) CFU BCG. Each participant received a single intradermal injection of their assigned vaccine in 0·1 mL sterile water in their non-dominant arm. The primary outcome was safety in all vaccinated participants. Secondary outcomes included whole blood cell-mediated immune response to live MTBVAC and BCG, and interferon γ release assays (IGRA) of peripheral blood mononuclear cells. This trial is registered with ClinicalTrials.gov, number NCT02013245. FINDINGS: Between Jan 23, 2013, and Nov 6, 2013, we enrolled 36 volunteers into three cohorts, each of which consisted of nine participants who received MTBVAC and three who received BCG. 34 volunteers completed the trial. The safety of vaccination with MTBVAC at all doses was similar to that of BCG, and vaccination did not induce any serious adverse events. All individuals were IGRA negative at the end of follow-up (day 210). After whole blood stimulation with live MTBVAC or BCG, MTBVAC was at least as immunogenic as BCG. At the same dose as BCG (5×10(5) CFU), although no statistical significance could be achieved, there were more responders in the MTBVAC group than in the BCG group, with a greater frequency of polyfunctional CD4+ central memory T cells. INTERPRETATION: To our knowledge, MTBVAC is the first live-attenuated M tuberculosis vaccine to reach clinical assessment, showing similar safety to BCG. MTBVAC seemed to be at least as immunogenic as BCG, but the study was not powered to investigate this outcome. Further plans to use more immunogenicity endpoints in a larger number of volunteers (adults and adolescents) are underway, with the aim to thoroughly characterise and potentially distinguish immunogenicity between MTBVAC and BCG in tuberculosis-endemic countries. Combined with an excellent safety profile, these data support advanced clinical development in high-burden tuberculosis endemic countries. FUNDING: Biofabri and Bill &amp; Melinda Gates Foundation through the TuBerculosis Vaccine Initiative (TBVI)

MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studies

A single intradermal vaccination with MTBVAC given to adult rhesus macaques was well tolerated and conferred a significant improvement in outcome following aerosol exposure to M. tuberculosis compared to that provided by a single BCG vaccination. Vaccination with MTBVAC resulted in a significant reduction in M. tuberculosis infection-induced disease pathology measured using in vivo medical imaging, in gross pathology lesion counts and pathology scores recorded at necropsy, the frequency and severity of pulmonary granulomas and the frequency of recovery of viable M. tuberculosis from extrapulmonary tissues following challenge. The immune profiles induced following immunisation with MTBVAC reflect those identified in human clinical trials of MTBVAC. Evaluation of MTBVAC- and TB peptide-pool-specific T-cell cytokine production revealed a predominantly Th1 response from poly- (IFN-¿+TNF-a+IL2+) and multi-(IFN-¿+TNF-a+) functional CD4 T cells, while only low levels of Th22, Th17 and cytokine-producing CD8 T-cell populations were detected together with low-level, but significant, increases in CFP10-specific IFN-¿ secreting cells. In this report, we describe concordance between immune profiles measured in clinical trials and a macaque pre-clinical study demonstrating significantly improved outcome after M. tuberculosis challenge as evidence to support the continued development of MTBVAC as an effective prophylactic vaccine for TB vaccination campaigns

Characterization of rice yield based on biomass and SPAD-based leaf nitrogen for large genotype plots

The use of Unmanned Aerial Vehicle (UAV) images for biomass and nitrogen estimation offers multiple opportunities for improving rice yields. UAV images provide detailed, high-resolution visual information about vegetation properties, enabling the identification of phenotypic characteristics for selecting the best varieties, improving yield predictions, and supporting ecosystem monitoring and conservation efforts. In this study, an analysis of biomass and nitrogen is conducted on 59 rice plots selected at random from a more extensive trial comprising 400 rice genotypes. A UAV acquires multispectral reflectance channels across a rice field of subplots containing different genotypes. Based on the ground-truth data, yields are characterized for the 59 plots and correlated with the Vegetation Indices (VIs) calculated from the photogrammetric mapping. The VIs are weighted by the segmentation of the plants from the soil and used as a feature matrix to estimate, via machine learning models, the biomass and nitrogen of the selected rice genotypes. The genotype IR 93346 presented the highest yield with a biomass gain of 10,252.78 kg/ha and an average daily biomass gain above 49.92 g/day. The VIs with the highest correlations with the ground-truth variables were NDVI and SAVI for wet biomass, GNDVI and NDVI for dry biomass, GNDVI and SAVI for height, and NDVI and ARVI for nitrogen. The machine learning model that performed best in estimating the variables of the 59 plots was the Gaussian Process Regression (GPR) model with a correlation factor of 0.98 for wet biomass, 0.99 for dry biomass, and 1 for nitrogen. The results presented demonstrate that it is possible to characterize the yields of rice plots containing different genotypes through ground-truth data and VIs

Investigating nuclear structure near N=32 and N=34: Precision mass measurements of neutron-rich Ca, Ti, and V isotopes

Nuclear mass measurements of isotopes are key to improving our understanding of nuclear structure across the chart of nuclides, in particular, for the determination of the appearance or disappearance of nuclear shell closures. We present high-precision mass measurements of neutron-rich Ca, Ti, and V isotopes performed at TRIUMF's Ion Trap for Atomic and Nuclear science (TITAN) and the Low Energy Beam and Ion Trap (LEBIT) facilities. These measurements were made using the TITAN multiple-reflection time-of-flight mass spectrometer (MR-ToF-MS) and the LEBIT 9.4T Penning trap mass spectrometer. In total, 13 masses were measured, 8 of which represent increases in precision over previous measurements. These measurements refine trends in the mass surface around N=32 and N=34, and support the disappearance of the N=32 shell closure with increasing proton number. Additionally, our data do not support the presence of a shell closure at N=34.Nuclear mass measurements of isotopes are key to improving our understanding of nuclear structure across the chart of nuclides, in particular for the determination of the appearance or disappearance of nuclear shell closures. We present high-precision mass measurements of neutron-rich Ca, Ti and V isotopes performed at the TITAN and LEBIT facilities. These measurements were made using the TITAN multiple-reflection time-of-flight mass spectrometer (MR-ToF-MS) and the LEBIT 9.4T Penning trap mass spectrometer. In total, 13 masses were measured, eight of which represent increases in precision over previous measurements. These measurements refine trends in the mass surface around $N = 32$ and $N = 34$, and support the disappearance of the $N = 32$ shell closure with increasing proton number. Additionally, our data does not support the presence of a shell closure at $N = 34$